Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Streptococcus agalactiae infective endocarditis].

Javier Rodríguez-Granger1, Fuensanta Ruiz-López, Enrique Camacho-Muñoz

  • 1Servicios de Microbiología, Hospital Universitario Virgen de las Nieves, Granada, España. javierm.rodriguez.sspa@juntadeandalucia.es

Enfermedades Infecciosas Y Microbiologia Clinica
|June 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro activity of eravacycline against anaerobic bacteria isolated from clinically significant samples.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026
Same author

Entomological surveillance of dwellings and risk factors for autochthonous cases of human leishmaniasis in a European Mediterranean hotspot.

Acta tropica·2026
Same author

Evaluation of Commercial Immunoassays for Rubella Virus IgG Detection in Low-Antibody Sera Using a Recombinant Immunoblot as a Reference Method.

Microorganisms·2026
Same author

Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain-DDR Study.

Alimentary pharmacology & therapeutics·2026
Same author

Performance of two chemiluminescent assays in determining rubella IgG in sera with low levels of specific IgG.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2025
Same author

A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers.

Frontiers in immunology·2025
Same journal

New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Enfermedades infecciosas y microbiologia clinica·2025
Same journal

[Description of 12 HIV-positive patients who have had the COVID-19 in our area].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?]

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

Impact of COVID-19 on Madrid hospital system.

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[COVID-19 and influenza A coinfection: a matter of principle].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization.

Enfermedades infecciosas y microbiologia clinica·2024
See all related articles

Streptococcus agalactiae is a rare cause of infective endocarditis. This aggressive infection often leads to severe heart failure and necessitates early valve replacement surgery, with a 50% mortality rate observed in this study.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Microbiology

Background:

  • Streptococcus agalactiae (S. agalactiae) is an uncommon pathogen implicated in infectious endocarditis.
  • Infective endocarditis presents a significant clinical challenge, particularly when caused by less frequent microorganisms.

Purpose of the Study:

  • To delineate the clinical profile, therapeutic strategies, and outcomes of infective endocarditis caused by S. agalactiae.
  • To highlight the aggressive nature and potential complications associated with S. agalactiae endocarditis.

Main Methods:

  • Retrospective analysis of four cases of S. agalactiae infective endocarditis diagnosed between 1996 and 2003.
  • Review of clinical characteristics, echocardiographic findings, treatment interventions, and patient follow-up.

Related Experiment Videos

Main Results:

  • All four patients presented with native valve involvement and vegetations.
  • Severe aortic valve failure was a consistent finding, with three patients also experiencing heart failure.
  • All patients underwent valve replacement surgery, and the observed mortality rate was 50%.

Conclusions:

  • Infective endocarditis caused by S. agalactiae is a highly aggressive condition.
  • Prompt surgical intervention is crucial for preventing extensive valve damage and mitigating severe complications.
  • Early consideration of valve replacement surgery is recommended for patients diagnosed with S. agalactiae endocarditis.